… to identify anti-SARS-CoV-2 candidates using a combined approach of virtual screening and
molecular docking techniques. The information deriving from the screening will be useful in …

… SARS-CoV-2, was first identified in 2019 in Wuhan, China. The novel corona virus SARS-CoV-2
and the 2002 SARS-CoV … the SARS-CoV (6CRV: full length S protein) and SARS-CoV-2 …

… In this work, we aimed to apply a multi-stage virtual screening approach including 3D
pharmacophore, molecular docking, molecular dynamics, and MMPBSA calculations to screen the …

… oriented virtual screening campaigns to seek for novel chemical scaffolds for SARS-CoV-2 …
Some of them exhibited antiviral activity in the low micromolar range against SARS-CoV-2 …

… This study aims at screening a set of phytochemicals to find potent inhibitors of the main
protease of SARS-CoV-2, as a possible approach in the fight against COVID-19. Molecular …

… -2 causes the current global pandemic coronavirus disease … We applied the combination of
virtual screening based on … that could inhibit the 3CL pro of SARS-CoV-2. Three drugs were …

… as SARS-CoV-2 S-RBD/ACE2 interaction inhibitors. In this study, we described the virtual
screening … (DC-RA016 and DC-RA052) against SARS-CoV-2 S-RBD/ACE2 interaction. The …

Full article: Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual
screening, molecular docking and molecular dynamics with main protease as the target Skip …

… coronavirus 2 (SARS-CoV-2). The 3CL protease (3CLpro) is the main protease of the
SARS-CoV-2, … In this paper, we reported molecular docking-based virtual screening (VS) of 2000 …

Continuing our antecedent work against COVID‐19, a set of 5956 compounds of traditional
Chinese medicine have been virtually screened for their potential against SARS‐CoV‐2 …